Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Metastatic Bone Sarcoma · Metastatic Malignant Neoplasm in the Lung · Metastatic Soft Tissue Sarcoma · Metastatic Unresectable Sarcoma · Resectable Sarcoma · Colorectal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Roswell Park Cancer Institute, Buffalo, New York, United States
Contact: Study coordinator (Kenneth Seastedt, MD) · Kenneth.Seastedt@roswellpark.org · 716-845-8675
Contact: Principal Investigator (Kenneth Seastedt)

Study leads

Kenneth Seastedt
Principal Investigator
Roswell Park Cancer Institute

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

Neuroblastoma · Sarcoma

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Aurora, United States

Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas

Sarcoma · Sarcoma, Kaposi · Sarcoma, Ewing

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China

BIOmarker Driven Trial of VEGFR2 Inhibitor in Advanced or Metastatic Sarcoma

Sarcoma

Abroad (travel likely)RecruitingPHASE2

Shanghai, China

PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA)

Sarcoma · Sarcoma,Soft Tissue · Sarcoma of Bone

Abroad (travel likely)RecruitingPHASE2

Shanghai, China